Harvard Bioscience (HBIO) Intangibles (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Intangibles data on file, last reported at $60.4 million in Q1 2026.

• On a quarterly basis, Intangibles rose 496.18% year-over-year to $60.4 million in Q1 2026; TTM through Mar 2026 was $60.4 million, a 496.18% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, down 86.93% from the prior year.
• Intangibles for Q1 2026 stood at $60.4 million, up from $7.6 million in the prior quarter.
• Over the last five years, Intangibles for HBIO reached as high as $64.7 million in Q1 2022 and fell as low as $196000.0 in Q3 2023.
• Historically, Intangibles has averaged $29.3 million across 5 years, with a median of $19.6 million in 2023.
• Across the five-year window, Intangibles tumbled 99.69% in 2023 and surged 29957.0% in 2025, its largest moves.
• Year by year, Intangibles stood at $224000.0 in 2022, then surged by 26086.61% to $58.7 million in 2023, then declined by 0.35% to $58.5 million in 2024, then plunged by 86.93% to $7.6 million in 2025, then soared by 690.59% to $60.4 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $60.4 million in Q1 2026, $7.6 million in Q4 2025, and $218000.0 in Q3 2025.